SEATTLE, May 11, 2021, (MEDGADGET) — Overview:
DNA microarray or chip is a semiconductor state in which various genetic sequences are combined with investigations. DNA microarrays are used to measure expression levels of numbers of genes at the same time or genotype multiple regions of a genome. This approach finds the use of drug R&D, clinical diagnostics, agriculture, environmental management, and other fields.
Statistics:
The global array market (life science and biotechnology instruments) is estimated to account around US$ 4,899.9 Mn in terms of value in 2020 and is expected to reach US$ 12,892.5 Mn by the end of 2027.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/4221
Drivers:
High prevalence of cancer is expected to drive growth of the global array market (life science and biotechnology instruments) during the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Furthermore, growing acceptance of genetic testing is also expected to drive growth of the global array market (life science and biotechnology instruments) during the forecast period. For instance, in April 2020, Axovant Gene Therapies collaborated with Invitae Corporation, a provider of advanced medical genetics, to offer free genetic testing in the U.S. and Canada for pediatric lysosomal storage disease.
Statistics:
DNA Array hold dominant position in the global array market (life science and biotechnology instruments) in 2019, accounting over 50.3% share in terms of value, followed by Protein array and tissue array, respectively.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4221
Restraints:
The global array market (life science and biotechnology instruments) is expected to be hampered due to shortage of technically trained resources, especially in emerging economies. Technologically experienced and technical equipment is required to use DNA / gene microarrays and sequencers. The shortage of such skilled workers is expected to slow global array market (life science and biotechnology instruments) growth.
Furthermore, availability of alternative methods such as genomics, high-throughput sequencing, pharmacogenomics, combinatorial chemistry, tools, nanotechnology, bioinformatics, RNAi, proteomics, and bio-analytical, which are expected to hinder the global array market (life science and biotechnology instruments) growth during the forecast period.
Opportunities:
R&D in cancer is expected to pose growth opportunities for major players in the global array market (life science and biotechnology instruments). For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.
Moreover, significant development in personalized medicines is also expected to accelerate growth of the global array market (life science and biotechnology instruments) during the forecast period. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/array-market-life-science-and-biotechnology-instruments-3490
Statistics:
The global array market (life science and biotechnology instruments) is estimated to value around US$ 4,276.1 Mn in 2019 and is forecast to witness an account over US$ 12,892.5 Mn by 2027 at a CAGR of 14.8% between 2020 and 2027.
Market Trends/Key Takeaways
Key players in the global array market (life science and biotechnology instruments) are focusing on adoption of M&A strategies to enhance their market share. For instance, in December 2019, Oncology Pharma, Inc. signed a Letter of Intent to acquire at least a 50% stake in Diagnomics, Inc., a private CLIA certified & CAP accredited private molecular Genomics lab and provider of DNA microarrays, Next Generation Sequencing, and real-time PCR solutions
R&D in arrays is expected to drive growth of the global array market (life science and biotechnology instruments) during the forecast period. For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.
Market Segmentation:
- By Type:DNA Array, Protein Array, Tissue Array, and Cell Array.
- By End User:Biopharmaceutical and Pharmaceutical, Diagnostic Laboratories, Research Laboratories and Others.
Competitive Landscape:
Key players dominating in the global array market (life science and biotechnology instruments) including Illumina Inc., Naffymetrix Inc., Roche Diagnostics Inc., Life Technologies, Bio-Rad Laboratories, Caliper Life Sciences, Siemens Healthineers, Perkin Elmer, Inc., Agilent Technologies Inc., Twist Bioscience Corporation and PathogenDx, Inc.
Key Developments:
Key players in the global array market (life science and biotechnology instruments) are focusing on launching novel products to expand their product portfolio. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology
Moreover, in February 2018, Thermo Fisher Scientific launched the Applied Biosystems Axiom Microbiome Array for simultaneous detection of archaea, bacteria, fungi, protozoa and viruses in human and non-human samples.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/4221
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- Market Dynamics
- Global Array Market, By Type, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- DNA Array
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Protein Array
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Tissue Array
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Cell Array
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Array Market, By End User, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Biopharmaceutical and Pharmaceutical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Array Market, By Regions, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837